Lung Stereotactic Body Radiation Therapy in a Patient with Severe Lung Function Impairment Allowed by Gallium-68 Perfusion PET/CT Imaging: A Case Report.
François LuciaMohamed HamyaFanny PinotDavid BourhisPierre-Yves Le RouxPublished in: Diagnostics (Basel, Switzerland) (2023)
Lung stereotactic body radiotherapy (SBRT) is increasingly proposed, especially for patients with poor lung function who are not eligible for surgery. However, radiation-induced lung injury remains a significant treatment-related adverse event in these patients. Moreover, for patients with very severe COPD, we have very few data about the safety of SBRT for lung cancer. We present the case of a female with very severe chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in one second (FEV1) of 0.23 L (11%), for whom a localized lung tumor was found. Lung SBRT was the only possible treatment. It was allowed and safely performed, based on a pre-therapeutic evaluation of regional lung function with Gallium-68 perfusion lung positron emission tomography combined with computed tomography (PET/CT). This is the first case report to highlight the potential use of a Gallium-68 perfusion PET/CT in order to safely select patients with very severe COPD who can benefit from SBRT.
Keyphrases
- lung function
- pet ct
- radiation therapy
- positron emission tomography
- chronic obstructive pulmonary disease
- radiation induced
- cystic fibrosis
- computed tomography
- air pollution
- case report
- early onset
- locally advanced
- contrast enhanced
- minimally invasive
- high resolution
- pet imaging
- magnetic resonance imaging
- drug induced
- end stage renal disease
- emergency department
- early stage
- machine learning
- big data
- newly diagnosed
- magnetic resonance
- chronic kidney disease
- mass spectrometry
- electronic health record
- ejection fraction
- mechanical ventilation
- coronary artery bypass
- intensive care unit
- surgical site infection
- extracorporeal membrane oxygenation
- adverse drug